Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 12.7B | 13.5B | 11.4B | 11.3B |
Cost of revenue | 2.2B | 2.4B | 2.2B | 2.2B |
Gross profit | 10.5B | 11.1B | 9.3B | 9.1B |
Operating expense | ||||
Research & development | 2.7B | 3.0B | 2.7B | 2.7B |
Selling general and admin | 2.4B | 2.3B | 2.0B | 2.0B |
Other operating expenses | — | — | — | — |
Operating income | 5.4B | 5.8B | 4.5B | 4.4B |
Non operating interest income | ||||
Income | 48.3M | 44.3M | 47.8M | 37.3M |
Expense | 243.7M | 224.7M | 192.7M | 183.6M |
Other income expense | -1.8B | -578.7M | -2.8B | -755M |
Pretax income | 3.5B | 5.0B | 1.6B | 3.5B |
Tax provision | 696.8M | 628.9M | 618.1M | 550.2M |
Net income | 2.8B | 4.4B | 970.3M | 3.0B |
Basic EPS | 0.1 | 0.1 | 0.0 | 0.1 |
Diluted EPS | 0.1 | 0.1 | 0.0 | 0.1 |
Basic average shares | 37.1B | 37.0B | 37.2B | 37.2B |
Diluted average shares | 37.2B | 37.3B | 37.3B | 37.3B |
EBITDA | 5.9B | 6.3B | 5.0B | 4.9B |
Net income from continuing op. | 2.8B | 4.4B | 970.3M | 3.0B |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |